Product Description

Natlimus 0.25mg Tablet is a targeted therapy containing active constituent everolimus. It is used to treat hormone receptor-positive advanced breast cancer in post-menopausal women. It is also used to treat neuroendocrine tumours, brain tumours, and advanced kidney cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have had recent major surgery, unhealed wound following surgery, diabetes, liver disorders, high cholesterol, infection, hepatitis B, or if you need to receive a vaccine before taking this medicine.

 

Natlimus 0.25mg Tablet is not recommended for adolescents and children under the age of 18. Avoid taking grapefruit juice or grapefruit while taking this medicine. You need to tell your doctor about all the medications you are taking recently before taking this medicine. Use effective birth control during the treatment with this medicine. 

 

How to use

Use as directed

Uses

Used in Prevention of organ rejection in transplant patients
Treatment of Breast cancer
Treatment of Lung cancer

Side Effects

• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding

Storage

Store below 30℃